Newsworthy

The AFFIRM Study is looking for adults who are 18 years of age or older, with moderate to severe Crohn’s disease (CD). The study is researching a study drug to see if it can safely be given subcutaneously (an injection under the skin) with the goal of inducing “remission” in adults with CD. Remission is the point where CD symptoms start to go away or disappear completely. To see whether you might be eligible, please visit our website www.AFFIRMstudyCD.com, or contact the Stormont Vail Digestive Health Clinical Research Center to learn more: (785) 270-4856.